medigraphic.com
ISSN 1029-3043 (Electronic)

2022, Number 1

<< Back

Medicentro 2022; 26 (1)

Fibrosis indices, their application in the management of non-alcoholic fatty liver disease

Morales MI, Gil GL, Coronado HY

Language: Spanish
References: 10
Page: 229-238
PDF size: 584.39 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Singh S, Allen AM, Wang Z, Prokop J, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: A systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol [internet] 2015. [citado 15 mar 2021];13(4);[aprox. 11 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208976/

  2. Caballería LL, Augustin S, Broquetas T, Morillas RM, Vergara M, Virolés S, et al. Recomendaciones para la detección, diagnóstico y seguimiento de los pacientes con enfermedad por hígado graso no alcohólico en atención primaria y hospitalaria. Med Clin (Barc) [internet]. 2019. [citado 15 mar 2021];153(4); [aprox. 8 p.]. Disponible en: https://dugi-doc.udg.edu/bitstream/handle/10256/18161/RecomendacionesDeteccionByNcNd.pdf?sequence=1

  3. Bernal R, Castro G, Malé R, Carmona R, González MZ, García I, et al. Consenso mexicano de la enfermedad por hígado graso no alcohólico. Rev Gastroenterol Méx [internet]. 2019. [citado 15 mar 2021];84(1);[aprox. 30 p.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S0375090618301794

  4. Long MT, Pedley A, Massaro JM, Hoffmann U, Fox CS. The Association between Non-Invasive Hepatic Fibrosis Markers and Cardiometabolic Risk Factors in the Framingham Heart Study. PLoS ONE [internet]. 2016. [citado 15 mar 2021];11(6):[aprox. 7 p.]. Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157517

  5. Andrés MJ, Lou J, Escanero J, Serrano T, Puente J. Biomarcadores, índices y algoritmos para el diagnóstico de fibrosis hepática en pacientes con hepatitis crónica por virus C. Rev Laborator Clin [internet]. 2015 [citado 8 oct 2017];8(4):[aprox. 8 p.]. Disponible en: https://pesquisa.bvsalud.org/portal/resource/en;/ibc-146404

  6. Ochoa C, Calambás F. Hígado graso no alcohólico en consulta de gastroenterología. Repert Med Cir [internet]. 2017 [citado 8 oct 2017];26(4):[aprox. 5 p.]. Disponible en: https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/56

  7. Younossi ZM, Loomba R, Anstee QM, Rinella ME, Bugianesi E, Marchesini G. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis. Hepatology [internet]. 2018 [citado 8 oct 2017];68(1):[aprox. 11 p.]. Disponible en: https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.29721

  8. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology [internet]. 2018 [citado 8 de oct 2017];67(1):[aprox. 11 p.]. Disponible en: https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.29367

  9. Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterol [internet]. 2016 [citado 8 de ct 2017];150(3):[aprox. 11 p.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S0016508515017345

  10. Arab JP, Dirchwolf M, Álvares da Silva MR, Barrera F, Benítez C, Castellanos Fernandez M. Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease. Ann Hepatol [internet]. 2017 [citado 8 oct 2020];19(6):[aprox. 16 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33031970/




2020     |     www.medigraphic.com